Maria Sorokina - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Maria Sorokina

Showing results (31-40 of 34) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 34 results.

Nature Medicine|June 17, 2024

Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trialSteven M Horwitz, Ajit J Nirmal, Jahan Rahman, et al.

Journal of Cheminformatics|September 7, 2021

Computational Applications in Secondary Metabolite Discovery (CAiSMD): an online workshopFidele Ntie-Kang, Kiran K Telukunta, Serge A T Fobofou, et al.

Nature Reviews. Drug Discovery|September 11, 2023

Artificial intelligence for natural product drug discoveryMichael W Mullowney, Katherine R Duncan, Somayah S Elsayed, et al.

Cell Reports. Medicine|March 27, 2025

A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilitiesDanilo Fiore, Luca Vincenzo Cappelli, Liu Zhaoqi, et al.

Pageof 4

Search research articles

Showing results (31-40 of 34) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 34 results.

Nature Medicine|June 17, 2024

Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trialSteven M Horwitz, Ajit J Nirmal, Jahan Rahman, et al.

Journal of Cheminformatics|September 7, 2021

Computational Applications in Secondary Metabolite Discovery (CAiSMD): an online workshopFidele Ntie-Kang, Kiran K Telukunta, Serge A T Fobofou, et al.

Nature Reviews. Drug Discovery|September 11, 2023

Artificial intelligence for natural product drug discoveryMichael W Mullowney, Katherine R Duncan, Somayah S Elsayed, et al.

Cell Reports. Medicine|March 27, 2025

A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilitiesDanilo Fiore, Luca Vincenzo Cappelli, Liu Zhaoqi, et al.

Pageof 4